Basic tasks can be a pain in the you-know-what when arthritis is part of your life. The aching, the swelling, the joint pain — who needs it? No one, which is why so many folks turn to Copper ...

Anzupgo (delgocitinib) is the first and only topical medication specifically approved for adults with moderate to severe chronic hand eczema. In large clinical trials, the cream significantly improved ...

As many as two billion people suffer from it — including me. Can science finally bring us relief? Credit...Marcus Schaefer for The New York Times Supported by By Jennifer Kahn Jennifer Kahn is a ...

If a person hides their own hand and focuses on a rubber hand instead, they may perceive it as part of their own body under certain conditions. What sounds like a gimmick could one day be used to help ...

Delgocitinib is the first FDA-approved topical JAK inhibitor for moderate to severe chronic hand eczema in adults. The DELTA 1 and DELTA 2 studies showed significant efficacy, with improved patient ...

Chronic hand eczema affects emotional health, daily activities, and relationships, leading to social isolation and discrimination. The condition imposes financial burdens, impacting work performance ...

Pain and sleep disturbances often go hand in hand—more than 30% of the U.S. population lives with pain, and a majority of those with pain also report sleep disorders—but the relationship between the ...

It goes without saying that we are capable of noticing changes to our bodies, but it's perhaps less obvious that the way we perceive our bodies can affect them physically. The two-way nature of this ...